Article
Muscarinic receptors downregulation is associated with increased IL6 expression in brain samples of individuals with schizophrenia
2025-05-16
Abstract excerpt
Acetylcholine plays a role in the immune system with notable anti-inflammatory properties. Xanomeline, a muscarinic acetylcholine receptor agonist, was recently approved for schizophrenia, marking the first therapy of its kind. Evidence suggests two molecular subtypes of schizophrenia: one characterized by reduced muscarinic receptor expression (muscarinic receptor-deficit schizophrenia, MRDS), and another marked...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 096fd641-df27-594b-b12b-eb5b32ad475f
- DOI
- 10.22541/au.174736650.05448372/v1
